ON
Oncopeptides AB (publ)
ONCO.ST · STO
1.67 kr +2.77% (+0.04 kr)
1M -4.68%
Market Cap 393.2M kr
P/E Ratio -
Div. Yield -
ROE 1,725.84%
Bulios Fair Price
2.45 kr
46.7% upside
Trenutna cena
1.67 kr
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ONCO.ST trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
22 /100
Expensive P/B 15.77x
P/S 4.13x
EV/FFO N/A
Growth
100 /100
Growing Rev. growth 104.18%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 211.09%
Gross margin 96.40%
FCF margin 210.11%
Quality
5 /100
Poor ROA 95.92%
ROIC 121.44%
Asset turnover 0.43x
Debt
23 /100
High Int. coverage -9.10x
Debt/Equity 5.42x
Current ratio 3.78x
Stability
40 /100
Moderate EPS volatility 19.86%
Beta -1.31x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ONCO.ST
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Sofia Heigis
Employees
69
Headquarters
Stockholm
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report